The nail disorder treatment product market is projected to grow from USD 4.4 billion in 2026 to USD 8.8 billion by 2036, at a CAGR of 7.2%. Topical antifungal drugs will dominate with a 34.0% market share, while onychomycosis will lead the disease indications segment with a 42.0% share.